Intersect Systems, Inc.
United StatesFDA applicant, unverified
- Devices
- 21
What Intersect Systems, Inc. makes
Intersect Systems, Inc. manufactures enzymatic and reagent-based diagnostic products for clinical laboratory testing, including glucose oxidase reagents, triglyceride and cholesterol assay kits, bilirubin and enzyme-specific reagents (such as amylase, CK-NAC, and GGT), and carbon dioxide measurement reagents. The company also produces the MINI-PECG, a device for point-of-care coagulation testing, alongside chloride and albumin reagents for serum chemistry analysis.
The portfolio includes devices classified under FDA’s Class I and Class II categories, with regulatory submissions recorded via the 510(k) pathway. These products are intended for in vitro diagnostic use and are listed in the FDA’s 510(k) database. The manufacturer is based in the United States.
Catalogue
Search and filter all 21 devicesFrequently asked questions
How many devices does Intersect Systems, Inc. have in the registry?
The registry currently lists 21 devices for Intersect Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Intersect Systems, Inc.'s devices?
Among its 21 most recently registered devices, Intersect Systems, Inc. has devices listed in FDA 510(k) (21 devices).
What risk classes do Intersect Systems, Inc.'s devices fall under?
Among its 21 most recently registered devices, the classes recorded for Intersect Systems, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Intersect Systems, Inc. in the registry?
The most recently registered devices listed for Intersect Systems, Inc. include GLUCOSE OXIDASE REAGENT, INTERSECT SYSTEMS DIRECT AMYLASE REAGENT, INTERSECT SYSTEMS TRIGLYCERIDE-GPO REAGENT and ENZYMATIC CO2 REAGENT, MODIFICATION.